Dissecting the gray zone between follicular lymphoma and marginal zone lymphoma using morphological and genetic features

Haematologica

Volumn 98, Issue 12, 2013, Pages 1921-1929

  Krijgsman, Oscar ^a   Gonzalez, Patricia ^b   Ponz, Olga Balagué ^b   Roemer, Margaretha G M ^b   Slot, Stefanie ^b   Broeks, Annegien ^b   Braaf, Linde ^b   Kerkhoven, Ron M ^b   Bot, Freek ^c   van Groningen, Krijn ^d   Beijert, Max ^e   Ylstra, Bauke ^a   de Jong, Daphne ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c HAGA HOSPITAL   (Netherlands)

^d Kennemer Gasthuis ^*  (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; CYCLIN DEPENDENT KINASE 6; IKAROS TRANSCRIPTION FACTOR; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN BCL 6;

ADULT; AGED; ARHGEF12 GENE; ARTICLE; CBLB GENE; CHROMOSOME 3; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; COMPARATIVE GENOMIC HYBRIDIZATION; COMPARATIVE STUDY; COPY NUMBER VARIATION; EBF1 GENE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLICULAR LYMPHOMA; FOXP1 GENE; GENE; HUMAN; IMMUNOPHENOTYPING; LPP GENE; MAJOR CLINICAL STUDY; MALT1 GENE; MARGINAL ZONE LYMPHOMA; MSI2 GENE; NODAL MARGINAL ZONE LYMPHOMA; POLYMERASE CHAIN REACTION; RAD51L1 GENE; RANBP17 GENE; TFG GENE; USP6 GENE; VERY ELDERLY; WHSC1L1 GENE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED;

EID: 84889844937     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2013.085118     Document Type: Article

References (34)

1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (ed 4th). Lyon, France: IARC Press; 2008.
2. Rinaldi A, Mian M, Chigrinova E, Arcaini L, Bhagat G, Novak U, et al. Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome. Blood. 2011;117(5):1595-604.
3. Leich E, Salaverria I, Bea S, Zettl A, Wright G, Moreno V, et al. Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations. Blood. 2009;114(4):826-34.
4. Katzenberger T, Kalla J, Leich E, Stöcklein H, Hartmann E, Barnickel S, et al. A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36. Blood. 2009;113(5):1053-61.
5. Costa JL, Meijer G, Ylstra B, Caldas C. Array comparative genomic hybridization copy number profiling: a new tool for translational research in solid malignancies. Semin Radiat Oncol. 2008;18(2):98-104.
6. Fenton JA, Vaandrager JW, Aarts WM, Bende RJ, Heering K, van Dijk M, et al. Follicular lymphoma with a novel t(14;18) breakpoint involving the immunoglobulin heavy chainswitch mu region indicates an origin from germinal center B cells. Blood. 2002;99(2):716-8.
7. Ventura RA, Martin-Subero JI, Jones M, McParland J, Gesk S, Mason DY, et al. FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue. J Mol Diagn. 2006;8(2):141-51.
8. Schraders M, de Jong D, Kluin P, Groenen P, van Krieken H. Lack of Bcl-2 expression in follicular lymphoma may be caused by mutations in the BCL2 gene or by absence of the t(14;18) translocation. J Pathol. 2005;205(3):329-35.
9. van Beers EH, Joosse SA, Ligtenberg MJ, Fles R, Hogervorst FB, Verhoef S, et al. A multiplex PCR predictor for aCGH success of FFPE samples. Br J Cancer. 2006;94(2):333-7.
10. Buffart TE, Israeli D, Tijssen M, Vosse SJ, Mrsić A, Meijer GA, et al. Across array comparative genomic hybridization: a strategy to reduce reference channel hybridizations. Genes Chromosomes Cancer. 2008;47(11):994-1004.
11. van de Wiel MA, Picard F, van Wieringen WN, Ylstra B. Preprocessing and downstream analysis of microarray DNA copy number profiles. Brief Bioinform. 2011;12 (1):10-21.
12. Venkatraman ES, Olshen AB. A faster circular binary segmentation algorithm for the analysis of array CGH data. Bioinformatics. 2007;23(6):657-63.
13. Leary RJ, Lin JC, Cummins J, Boca S, Wood LD, Parsons DW, et al. Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers. Proc Natl Acad Sci USA. 2008;105(42):16224-9.
14. Bierkens M, Krijgsman O, Wilting SM, Bosch L, Jaspers A, Meijer GA, et al. Focal aberrations indicate EYA2 and hsa-miR-375 as oncogene and tumor suppressor in cervical carcinogenesis. Genes Chromosomes Cancer. 2013;52(1):56-68.
15. Brosens RP, Haan JC, Carvalho B, Rustenburg F, Grabsch H, Quirke P, et al. Candidate driver genes in focal chromosomal aberrations of stage II colon cancer. J Pathol. 2010;221(4):411-24.
16. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, et al. A census of human cancer genes. Nat Rev Cancer. 2004;4(3):177-83.
17. Conrad DF, Pinto D, Redon R, Feuk L, Gokcumen O, Zhang Y, et al. Origins and functional impact of copy number variation in the human genome. Nature. 2010;464 (7289):704-12.
18. Hiddemann W, Buske C, Dreyling M, Weigert O, Lenz G, Forstpointner R, et al. Treatment strategies in follicular lymphomas: current status and future perspectives. J Clin Oncol. 2005;23(26):6394-9.
19. Höglund M, Sehn L, Connors JM, Gascoyne RD, Siebert R, Säll T, et al. Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas. Genes Chromosomes Cancer. 2004;39(3):195-204.
20. d'Amore F, Chan E, Iqbal J, Geng H, Young K, Xiao L, et al. Clonal evolution in t(14;18) positive follicular lymphoma, evidence for multiple common pathways, and frequent parallel clonal evolution. Clin Cancer Res. 2008;14(22):7180-7.
21. Cheung KJ, Johnson NA, Affleck JG, Severson T, Steidl C, Ben-Neriah S, et al. Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis. Cancer Res. 2010;70(22):9166-74.
22. O'Shea D, O'Riain C, Gupta M, Waters R, Yang Y, Wrench D, et al. Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation. Blood. 2009;113(10):2298-301.
23. Ross CW, Ouillette PD, Saddler CM, Shedden KA, Malek SN. Comprehensive analysis of copy number and allele status identifies multiple chromosome defects underlying follicular lymphoma pathogenesis. Clin Cancer Res. 2007;13(16):4777-85.
24. Makishima H, Jankowska AM, McDevitt MA, O'Keefe C, Dujardin S, Cazzolli H, et al. CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia. Blood. 2011;117(21):e198-206.
25. Arribas AJ, Campos-Martín Y, Gómez-Abad C, Algara P, Sánchez-Beato M, Rodriguez-Pinilla MS, et al. Nodal marginal zone lymphoma: gene expression and miRNA profiling identify diagnostic markers and potential therapeutic targets. Blood. 2012;119(3): e9-e21.
26. Glas AM, Kersten MJ, Delahaye LJ, Witteveen AT, Kibbelaar RE, Velds A, et al. Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment. Blood. 2005;105(1):301-7.
27. Glas AM, Knoops L, Delahaye L, Kersten MJ, Kibbelaar RE, Wessels LA, et al. Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma. J Clin Oncol. 2007;25(4):390-8.
28. Dave SS, Wright G, Tan B, Rosenwald A, Gascoyne RD, Chan WC, et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med. 2004;351(21): 2159-69.
29. Novak AJ, Slager SL, Fredericksen ZS, Wang AH, Manske MM, Ziesmer S, et al. Genetic variation in B-cell-activating factor is associated with an increased risk of developing B-cell non-Hodgkin lymphoma. Cancer Res. 2009;69(10):4217-24.
30. Horsman DE, Okamoto I, Ludkovski O, Le N, Harder L, Gesk S, et al. Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypes. Br J Haematol. 2003;120(3):424-33.
31. Jardin F, Gaulard P, Contentin N, Lepretre S, Lenanin P, Stamatoullas A, et al. Follicular lymphoma without t(14;18) and with BCL6 rearrangements: a lymphoma subtype with distinct pathological, molecular and clinical characteristics. Leukemia. 2002;16(11): 2309-17.
32. Karube K, Guo Y, Suzymiya Y, Nomura Y, Yamamoto K, Shimizu K, et al. CD10-MUM1+ follicular lymphoma lacks BCL2 gene translcation and shows characteristic biologic and clinical features. Blood. 2007;109(7):3076-9.
33. Braggio E, Dogan A, Keats JJ, Chng WJ, Huang G, Matthews JM, et al. Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities. Mod Pathol. 2012;25(5):651-60.
34. Tagawa H, Karube K, Guo Y, Takeshita M, Kikuchi M, Morishima Y, et al. Trisomy 3 is a specific genomic aberration of t(14;18) negative follicular lymphoma. Leukemia 2007;21:2549-51.